Ying Lu

Ying Lu

Auto-generated profile, based on publicly available information

Ying Lu

National Clinical Research Center for Geriatrics, Center for Immunology and Hematology and General Practice Ward/International Medical Center Ward, General Practice Medical Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2025 in Nature Aging
Verified
Journal Article
Closed access
PDF file
YLYu Liu
Yu Liu
MGMeiling Ge
Meiling Ge
XXXina Xiao
Xina Xiao
YLYing Lu
Ying Lu
WZWanyu Zhao
Wanyu Zhao
LDLunzhi Dai
Lunzhi Dai

6 February 2024 in Nature Aging
Verified
Journal Article
Open access
PDF file
XWXinyuan Wang
Xinyuan Wang
YLYaru Luo
Yaru Luo
SHSiyu He
Siyu He
YLYing Lu
Ying Lu
YGYanqiu Gong
Yanqiu Gong
LDLunzhi Dai
Lunzhi Dai
The incidence of intestinal diseases increases with age, yet the mechanisms governing gut aging and its link to diseases, such as colorectal cancer (CRC), remain elusive. In this study, while considering age, sex and proximal–distal variations, we used a multi-omics approach in non-human primates (Macaca fascicularis) to shed light on the heterogeneity of intestinal aging and identify potential regulators of gut aging. We explored the roles of several regulators, including those from tryptophan metabolism, in intestinal function and lifespan inCaenorhabditis elegans. Suggesting conservation of region specificity, tryptophan metabolism via the kynurenine and serotonin (5-HT) pathways varied between the proximal and distal colon, and, using a mouse colitis model, we observed that distal colitis was more sensitive to 5-HT treatment. Additionally, using proteomics analysis of human CRC samples, we identified links between gut aging and CRC, with high HPX levels predicting poor prognosis in older patients with CRC. Together, this work provides potential targets for preventing gut aging and associated diseases.

25 July 2024 in Genomics, Proteomics & Bioinformatics
Verified
Journal Article
Open access
PDF file
RZRou Zhang
Rou Zhang
MHMeng Hu
Meng Hu
YLYu Liu
Yu Liu
WLWanmeng Li
Wanmeng Li
ZXZhiqiang Xu
Zhiqiang Xu
LDLunzhi Dai
Lunzhi Dai
Magnesium (Mg) deficiency is associated with increased risk and malignancy in colorectal cancer (CRC), yet the underlying mechanisms remain elusive. Here, we used genomic, proteomic, and phosphoproteomic data to elucidate the impact of Mg deficiency on CRC. Genomic analysis identified 160 genes with higher mutation frequencies in Low-Mg tumors, including key driver genes such as KMT2C and ERBB3. Unexpectedly, initiation driver genes of CRC, such as TP53 and APC, displayed higher mutation frequencies in High-Mg tumors. Additionally, proteomic and phosphoproteomic data indicated that low Mg content in tumors may activate epithelial–mesenchymal transition (EMT) by modulating inflammation or remodeling the phosphoproteome of cancer cells. Notably, we observed a negative correlation between the phosphorylation of DBN1 at S142 (DBN1S142p) and Mg content. A mutation in S142 to D (DBN1S142D) mimicking DBN1S142p up-regulated MMP2 and enhanced cell migration, while treatment with MgCl2 reduced DBN1S142p, thereby reversing this phenotype. Mechanistically, Mg2+ attenuated the DBN1–ACTN4 interaction by decreasing DBN1S142p, which in turn enhanced the binding of ACTN4 to F-actin and promoted F-actin polymerization, ultimately reducing MMP2 expression. These findings shed new light on the crucial role of Mg deficiency in CRC progression and suggest that Mg supplementation may be a promising preventive and therapeutic strategy for CRC.

8 February 2020 in Advances in Polymer Technology
Verified
Journal Article
Open access
PDF file
MCMiaoliang Chen
Miaoliang Chen
YLYing Lu
Ying Lu
RZRuili Zhang
Ruili Zhang
TBTienan Bi
Tienan Bi
SZShenkang Zhou
Shenkang Zhou
Objective. To study the effects of Huaier polysaccharide SP1 on the proliferation, apoptosis, migration, and invasion of gastric cancer cell line MGC-803 and the underlying mechanism. Methods. MGC-803 cells were cultured in vitro and treated with SP1. The effects of SP1 on the proliferation, apoptosis, migration, and invasion of MGC-803 cells were detected by CCK-8 assay, flow cytometry analysis, and Transwell assay, respectively. Western blot and qRT-PCR were used to detect the expression of related genes. Results. Our study showed that Huaier polysaccharide SP1 could inhibit proliferation, migration, invasion, and promote the apoptosis of MGC-803 cells in vitro in a dose-dependent manner. Huaier polysaccharide SP1 could inhibit the activation of TGF-β/SMAD signal pathway by upregulating SMAD7 expression, thereby downregulating the expression of SOX4, ZEB2, MMP9, Snail, and Slug. Conclusion. Huaier polysaccharide SP1 can regulate the proliferation, apoptosis, migration, and invasion of gastric cancer cells by promoting the expression of SMAD7 and inhibiting the activation of TGF-β/SMAD signal pathway as well as the expression of the downstream oncogenes.

1 January 2008
Verified
Conference Paper
Closed access
BTBaozhuang Tao
Baozhuang Tao
YZYichao Zhang
Yichao Zhang
YLYing Lu
Ying Lu
WLWei Li
Wei Li
With core device 8051 micro-controller and expanding IO-port through Intel 8255A to gather multi-channel signal ,and the final results of data processing are sent out through serial ports. The paper, based on the characteristic of bit operation of 51-series single-chip and by means of analysis method of mathematical statistics, develops a low-cost, simple- structure, reliable-function and highly efficient-algorithm signal acquisition unit model ,which supplies parallel or serial communication interface and can be further developed.

6 October 2026 in Nature Aging
Verified
Journal Article
Open access
PDF file
XWXinyuan Wang
Xinyuan Wang
YLYaru Luo
Yaru Luo
SHSiyu He
Siyu He
YLYing Lu
Ying Lu
YGYanqiu Gong
Yanqiu Gong
LDLunzhi Dai
Lunzhi Dai